The suppression of cell growth with alectinib + TNKS1/2 inhibitor was similar to those observed with XAV939 in neuroblastoma cell lines38, lung adenocarcinoma cells39, and small cell lung cancer cells in vitro40. This evidence concerns the gene TNKS and neuroblastoma.